Endonovo Therapeutics Inc (ENDV)

[©PROPHETABLE]

***ENDV…A DIAMOND IN THE ROUGH (DD BELOW)***
A RECENTLY UPDATED SHARE STRUCTURE (CONFIRMED BY TA):

NOW LET’S LOOK AT SOME UPCOMING CATALYSTS (PRE-CLINICAL STUDY THOUGHT TO BE COMPLETED THE FIRST QUARTER OF 2017):

AN ANONYMOUS STRATEGIC INVESTOR INVESTED $5 MILLION TO RETIRE CONVERTIBLE DEBT (THIS LED TO THE LAUNCHING OF PRE-CLINICAL TRIALS), ALSO NOTE HOW THE CEO STATED THAT HE BELIEVES THE STOCK IS “CONSIDERABLY UNDERVALUED”:

HERE IS A PHOTO OF THEIR IMMUNOTRONICS DEVICE:

NOW YOU MIGHT BE ASKING, “IS THERE A PATENT FOR THIS DEVICE?”…WELL…YES!!!

AND YOU MIGHT BE HAPPY TO KNOW THAT THEY HAVE FILED FOR SEVERAL OTHER PATENTS, TAKE A LOOK AT THE PATENTS DONNIE RUDD OWNS:

ENDONOVO HAS ALSO BEGUN TO FILE FOR ORPHAN DRUG STATUS!!!

ENDV HAS ALSO RECEIVED 2.2 MILLION TO BUY BACK CONVERTIBLE NOTES…OH…THE CURRENT MARKET CAP IS 2.2 MILLION AS WELL :)

ENDV ALSO HAS PLANS TO UPLIST!!!

ENDV WON THEIR PRELIM INJUNCTION AGAINST KODIAK AS WELL AND THEY ARE SEEKING A PERMANENT INJUNCTION:

NOW WHY WOULD THE COMPANY WANT TO HAVE THE SHARE PRICE DROP AT THIS TIME??? IS IT BECAUSE THE PRE-CLINICAL TRIALS ARE TO BE COMPLETED IN 2017, OR BECAUSE ALL NOTES ARE BEING RETIRED??? OR BECAUSE THEY HAVE A PENDING ORPHAN DRUG STATUS??? OR BECAUSE OF THEIR PATENTS??? WELL IF THEY WANTED IT THIS LOW, WHY AREN’T THEY BUYING BACK SHARES??? SHOULD’NT WE SEE A TON OF FORM 4’S??? WELL HERE YOU ARE:










TO END, LET’S LOOK AT THE CHART…ABOUT TO BREAK THE WEDGE AND MOVE INTO BLUE SKY TERRITORY:

THANKS...LOAD UP AND GOOD LUCK…